Hawaii 2024 Regular Session

Hawaii Senate Bill SCR159

Introduced
3/8/24  
Refer
3/14/24  
Introduced
3/8/24  
Report Pass
4/3/24  
Refer
3/14/24  
Engrossed
4/4/24  
Report Pass
4/3/24  
Refer
4/5/24  
Engrossed
4/4/24  

Caption

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Biomarker Testing.

Impact

The resolution emphasizes that biomarker testing is an essential component of personalized healthcare, allowing healthcare providers to tailor treatment plans based on specific biomarkers present in a patient’s biological samples. By improving access to such testing, the resolution aims to enhance patient care and outcomes. The Auditor's assessment will provide empirical data that can inform legislative decisions about potential healthcare policy changes and their financial ramifications for insurers and patients alike.

Summary

SCR159, known as the Senate Concurrent Resolution, requests the Auditor to assess the social and financial effects of mandating health insurance coverage for biomarker testing in Hawaii. The resolution aims to explore the implications of mandatory coverage on health insurance policies, specifically regarding House Bill No. 2223, which proposes that insurers, mutual benefit societies, and health maintenance organizations provide coverage for medically necessary biomarker testing. This type of testing is acknowledged as vital for the diagnosis and treatment of various diseases, offering a more individualized approach to medical care.

Contention

While proponents argue that mandatory coverage will improve access to necessary medical testing and help in the effective management of diseases, there may be concerns regarding the financial burden this could place on insurance providers and the healthcare system as a whole. Additionally, the commitment to comprehensive coverage might face opposition from stakeholders worried about increased healthcare costs potentially being passed onto consumers. The Auditor's report will play a crucial role in addressing these points of contention by providing a thorough analysis of the expected social and economic impacts.

Companion Bills

HI HCR53

Same As Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Biomarker Testing.

Previously Filed As

HI HCR53

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Biomarker Testing.

HI SCR29

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Biomarker Testing.

HI HCR35

Requesting The Auditor To Assess The Social And Financial Effects Of Mandatory Health Insurance Coverage For Biomarker Testing.

HI SCR62

Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage.

HI SCR120

Requesting The Auditor To Assess The Social And Financial Effects Of Proposed Mandatory Health Insurance Coverage For Continuous Glucose Monitors.

HI SCR17

Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage For Services Provided By Pharmacists.

HI SCR29

Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage For Services Provided By Pharmacists.

HI SCR123

Requesting The Auditor To Conduct A Social And Financial Assessment Of Proposed Mandatory Health Insurance Coverage For Early Access Breast Cancer Screening.

HI HCR171

Requesting The Auditor To Assess The Social And Financial Effects Of Proposed Mandatory Health Insurance Coverage For Continuous Glucose Monitors.

HI SR101

Requesting The Auditor To Assess The Social And Financial Effects Of Proposed Mandatory Health Insurance Coverage For Continuous Glucose Monitors.

Similar Bills

CA AB395

Substance use treatment providers.

AZ HB2745

Court-ordered treatment; enhanced services

AZ SB1310

Court-ordered treatment; enhanced services.

AZ HB2944

Inpatient treatment days; computation; exclusion

CA SB349

California Ethical Treatment for Persons with Substance Use Disorder Act.

AZ HB2041

Mental health; voluntary evaluations; payment

CA AB1230

Gambling disorder prevention.

IA HF574

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans.(Formerly HF 479.)